Early stopping clinical trials of binomial response with an exact group sequential method

Statistics in Medicine

Volumn 26, Issue 8, 2007, Pages 1724-1729

  Zhao, Zhen ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Clinical trials; Exact; Group sequential methods; Stopping

Indexed keywords

ARTICLE; BINOMIAL DISTRIBUTION; CLINICAL DECISION MAKING; CLINICAL RESEARCH; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT ERROR; METHODOLOGY; POWER ANALYSIS; SEQUENTIAL ANALYSIS; TUBERCULOSIS;

BINOMIAL DISTRIBUTION; CLINICAL TRIALS, PHASE II; DATA INTERPRETATION, STATISTICAL; HUMANS; TUBERCULOSIS;

EID: 33947356688     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2807     Document Type: Article

References (4)

1. Fleming TR. One-sample multiple testing procedure for Phase II clinical trials. Biometrics 1982; 38:143-151.
2. Schultz JR, Nichol FR, Elfring GL, Weed SD. Multiple-stage procedures for drug screening. Biometrics 1973; 29:293-300.
3. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
4. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC: Boca Raton, FL, 2000.